BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14720367)

  • 1. [Expression and structure of BNIP3L in lung cancer].
    Sun JL; He XS; Yu YH; Chen ZC
    Ai Zheng; 2004 Jan; 23(1):8-14. PubMed ID: 14720367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
    Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CIAPIN1 expression in human lung cancer tissues and inhibitory effects of the gene on human pulmonary carcinoma NCI-H446 cells].
    Wang Y; Qi HW; Li XH; Chen XX; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):434-7. PubMed ID: 18466694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of a new lung cancer drug resistance-related gene in lung cancer tissues and lung cancer cell strains].
    Liu LZ; Qian GS; Zhou XD
    Ai Zheng; 2003 Feb; 22(2):171-4. PubMed ID: 12600294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of endoplasmic reticulum molecular chaperon GRP94 in human lung cancer tissues and its clinical significance.
    Wang Q; An L; Chen Y; Yue S
    Chin Med J (Engl); 2002 Nov; 115(11):1615-9. PubMed ID: 12609072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of different RASSF1 transcripts and its clinical significance in lung carcinoma].
    Shao K; He J; Cheng BC; Xiao ZX; Zhang DC; Huang W; Zhang CY; Zhou F; Xiong MH; Tang HJ; Shi SS; Mu BD
    Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):149-52. PubMed ID: 12795841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
    Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
    Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
    Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of emodin on gene expression profile in small cell lung cancer NCI-H446 cells.
    Fu ZY; Han JX; Huang HY
    Chin Med J (Engl); 2007 Oct; 120(19):1710-5. PubMed ID: 17935676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transcriptional inactivation of RASSF1A in lung cancer and its clinical significance].
    Shao K; Xiao ZX; Tang HJ; Cheng BC; Zhang DC; Zhou F; Xiong MH; Mu BD; Huang W; Zhang CY; He J
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(7):569-71. PubMed ID: 12887746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.